Skip to main content
Edda Spiekerkoetter, MD, Pulmonology, Stanford, CA

Edda Frauke Spiekerkoetter MD

Critical Care Medicine


Acting Assistant Professor, Medicine - Pulmonary & Critical Care Medicine, Stanford University Medical Center

Join to View Full Profile
  • 300 Pasteur Drive RM H3143aStanford University Department of Medicine PCCMStanford, CA 94305

  • Phone+1 650-723-6381

Dr. Spiekerkoetter is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Summary

  • Spiekerkoetter Lab | Spiekerkoetter Lab | Stanford Medicine

    Led by Dr. Edda Spiekerkoetter, the Spiekerkoetter Lab research focuses on the importance of the Bone Morphogenetic Protein Receptor 2 (BMPR2) signaling pathway

Education & Training

  • Stanford Health Care-Sponsored Stanford University
    Stanford Health Care-Sponsored Stanford UniversityFellowship, Pulmonary Disease and Critical Care Medicine, 2008 - 2009
  • Stanford Health Care-Sponsored Stanford University
    Stanford Health Care-Sponsored Stanford UniversityFellowship, Pulmonary Disease and Critical Care Medicine, 2007 - 2008
  • Albert Ludwigs University Faculty of Medicine
    Albert Ludwigs University Faculty of MedicineClass of 1995

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 2009 - 2025

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011-2013

Clinical Trials

Publications & Presentations

PubMed

Grant Support

  • Understanding and targeting molecular and cellular events responsible for pulmonary arteriovenous malformation development, growth and regressionSTANFORD UNIVERSITY2023–2027
  • Vasculata 2024STANFORD UNIVERSITY2024–2025
  • Understanding and targeting molecular as well as structural events governing right ventricular adaptation, failure and recovery in pulmonary hypertension using repurposed drugsSTANFORD UNIVERSITY2021–2025

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: